Synthesis of Therapeutic Agents The promoter used for cloning HBV surface antigen is β-galactosidase galactokinase polyhedrin alcohol dehydrogenase 1 β-galactosidase galactokinase polyhedrin alcohol dehydrogenase 1 ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents The two chains of insulin can be separated by detaching it from β-galactosidase using protease hydrogen chloride peptidase cyanogen bromide protease hydrogen chloride peptidase cyanogen bromide ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents The gene coding for VP1 is cloned in pBR 322 pUC 18 pMB 9 pUC 19 pBR 322 pUC 18 pMB 9 pUC 19 ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents Which one of the following capsid protein of picorna virus is immunogenic in nature? VP2 VP3 VP4 VP1 VP2 VP3 VP4 VP1 ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents Recombinant vaccine for Hepatitis B virus has been synthesized against which of the following antigen? Viral surface antigen (HBsAg) Viral core antigen (HBcAg) All of these e antigen (HBeAg) Viral surface antigen (HBsAg) Viral core antigen (HBcAg) All of these e antigen (HBeAg) ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents In India first genetically engineered vaccine against HBV was developed by Glaxo Pvt Ltd Dabur Pvt Ltd Shantha Biotechnics Pvt Ltd Ranbaxy Pvt Ltd Glaxo Pvt Ltd Dabur Pvt Ltd Shantha Biotechnics Pvt Ltd Ranbaxy Pvt Ltd ANSWER DOWNLOAD EXAMIANS APP